AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
AMP 2026 exhibitors
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
183 organizations exhibit at AMP 2026, led by diagnostics, instrument, software and pharmaceutical companies. 69 of them also present on the scientific program, with 119 presentations between them. Most represented: Cincinnati Children's Hospital Medical Center, Natera and Nationwide Children's Hospital. As of Nov 12, 2026.
Program track
Top represented
Showing 1–30 of 183 organizations
| Organization | AMP 2026 Attendance |
|---|---|
Cincinnati Children's Hospital Medical Center Cincinnati, OH | |
Pediatric academic medical center whose laboratories offer clinical molecular and genetic testing to outside providers. | Booth Exhibiting at Booth 1713 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Session Fri, Nov 13 7:00am–8:00am Early Bird Case Study - Solid Tumors I
Talk Sat, Nov 14 1:45pm–2:15pm AMP Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working Group A working-group update on making genomic variant data interoperable in electronic health records, and where standards still fall short. Talk Sat, Nov 14 2:30pm–3:00pm A Clearer View of Structural Variation: The Role of Optical Genome Mapping in Genetic Disease and Pediatric Cancer Diagnostics Optical genome mapping resolves copy number and balanced structural changes that microarrays and short-read sequencing leave cryptic. |
Natera San Carlos, CA | |
Cell-free DNA testing company; Signatera is a custom ctDNA test for molecular residual disease assessment and treatment monitoring. | Booth Exhibiting at Booth 445 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 4:00pm–4:50pm Title: Advancements in MRD Testing: The Expanding Role of Digital Pathology and AI Digital pathology and machine learning applied to specimen assessment and interpretation in residual disease testing. Poster Thu, Nov 12 2:45pm–3:00pm |
Nationwide Children's Hospital Columbus, OH | |
Pediatric academic medical center in Columbus, Ohio; its genomic medicine institute runs clinical and research sequencing. | Booth Exhibiting at Booth 2008 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Session Thu, Nov 12 2:30pm–3:30pm Platform Presentations of Selected Informatics Abstracts I
Poster Thu, Nov 12 2:45pm–3:00pm Workshop Thu, Nov 12 4:25pm–4:55pm Want to get involved with AMP? Volunteering pathways in the professional society, from short time-limited tasks through committee membership and leadership roles. |
Promega Madison, WI | |
Nucleic acid extraction, PCR reagents and custom or OEM manufacturing for clinical laboratories, with technical support. | Booth Exhibiting at Booth 610 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am From Hands-On to Hands-Off: Automating FFPE, Blood, and Bone Marrow Extraction on the Clear Dx System Automated nucleic acid extraction from FFPE, blood and bone marrow, with yield reproducibility, contamination checks and time saved. Workshop Wed, Nov 11 9:00am–9:50am OncoMate® MSI Dx as a Companion Diagnostic for Microsatellite Instability: Clinical Context, Validation, and Performance Microsatellite instability testing as a companion diagnostic for checkpoint inhibitor eligibility, with accuracy and concordance data. |
Roche Diagnostics Indianapolis, IN | |
Clinical diagnostics, life science research, digital PCR and next-generation sequencing systems and assays for laboratories. | Booth Exhibiting at Booth 700 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Diamond Partner Workshop Wed, Nov 11 10:00am–10:50am Unlocking the Complete Lyo-Ready Workflow: From Sample Preparation to Amplification A shelf-stable reagent set spanning sample prep, reverse transcription and amplification for assays built without cold-chain storage. Workshop Wed, Nov 11 11:00am–11:50am Automated and Integrated Genomic Profiling of Hematologic Malignancies Sequencing workflows for blood cancers that report mutations, structural variants and clonal evolution in one automated run. Workshop Wed, Nov 11 12:00pm–12:50pm Next-Generation Sequencing with Roche’s AXELIOS 1 Platform Roche's AXELIOS 1 sequencer and its expansion-based chemistry, covering accuracy, read length and run flexibility. Workshop Wed, Nov 11 1:00pm–1:50pm Versatile Whole-exome Sequencing Enables End-to-end Phenotype-driven DNA-variant identification or RNA-fusion detection Phenotype-driven exome workflows for germline variant discovery, plus two RNA-sequencing routes to fusions. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. |
SOPHiA GENETICS Saint-Sulpice, Switzerland | |
SOPHiA AI platform for analyzing genomic and radiomic data, used by healthcare institutions for clinical research. | Booth Exhibiting at Booth 715 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am One Integrated Workflow from Tissue to Liquid Biopsy: Real-World Insights on MSK-IMPACT® Flex and MSK-ACCESS® powered with SOPHiA DDM™ One platform covering tissue and blood comprehensive genomic profiling, with real-world results from a cancer centre. Workshop Wed, Nov 11 9:00am–9:50am Analytical Performance of SOPHiA GENETICS MSK-IMPACT Flex on AVITI24 and Initial Compatibility of Trinity On-Flow Cell Hybrid Capture Verification data for a SOPHiA comprehensive genomic profiling panel on AVITI24, plus early results from Trinity on-flow-cell hybrid capture. Workshop Wed, Nov 11 9:00am–9:50am Scaling Decentralized Pan-Cancer Liquid Biospy: Multicentric Validation of MSK-ACCESS® powered with SOPHiA DDM™ Multi-site validation of a pan-cancer blood test, covering variants, copy number, fusions, MSI and circulating tumour DNA. |
Illumina San Diego, CA | |
Sequencing instruments and reagents for clinical, research and applied markets, spanning oncology, reproductive health and genetic disease. | Booth Exhibiting at Booth 727, MR1, MR2 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Gold Partner Workshop Wed, Nov 11 11:00am–11:50am Expanding Precision Oncology: Practical Strategies for Integrating Tissue and Liquid Biopsy Comprehensive Genomic Profiling Tissue and liquid biopsy genomic profiling run side by side, covering test algorithms, lab operations and case examples. Workshop Wed, Nov 11 12:00pm–12:50pm Genome as a Platform: Advancing MRD Research with Illumina Whole Genome Sequencing Oncology Prep Whole-genome sequencing as a single platform for molecular residual disease research, with early analytical performance data. Workshop Wed, Nov 11 2:00pm–2:50pm Unlocking AML Biology with 5-Base Whole-Genome Sequencing: Integrated Genomic and Epigenomic Profiling for Biomarker Discovery Five-base whole-genome sequencing reads methylation and genomic variation from one AML sample to find research biomarkers. Workshop Fri, Nov 13 3:00pm–3:30pm Comprehensive Tumor Profiling Beyond Panels: Methylation-Aware WGS Enabled by Advanced Informatics Whole-genome sequencing with methylation and fragmentomic analysis moves tumor profiling beyond targeted panels, using DRAGEN informatics. |
Bio-Rad Laboratories Hercules, CA | |
Products for life science research and clinical diagnostics, including droplet digital PCR, real-time PCR and molecular quality controls and standards. | Booth Exhibiting at Booth 537, MR16 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am MRD Detection & Monitoring in Solid Tumors and Heme Malignancies Using Personalized Tumor Informed Droplet Digital PCR (ddPCR) Assays in Research Settings Tumour-informed droplet digital PCR assays for tracking residual disease in both blood cancers and solid tumours. Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking More from Every Sample: New Multiplex Oncology Assays and Emerging MRD Applications with the QX700™ ddPCR™ System Multiplexed droplet digital PCR assays that pull more oncology biomarker data from limited samples, including residual disease monitoring. |
Foundation Medicine Boston, MA | |
Molecular information company providing comprehensive genomic profiling to inform cancer treatment decisions. | Booth Exhibiting at Booth 1701, MR14 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Molecular Residual Disease in Breast Cancer: Advancing Surveillance and Clinical Decision-Making Tissue-informed circulating tumor DNA testing in breast cancer, from baseline through surveillance and early recurrence detection. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. Talk Thu, Nov 12 7:15am–8:15am Adapting Communication Strategies for Today's Pathology Learners (A Special EdCoP Event) Teaching pathology trainees across generations and learning styles, including feedback and handling performance problems. |
New England Biolabs Ipswich, MA | |
Molecular biology reagents and enzymes for PCR and qPCR, sequencing library preparation, genome editing, epigenetics, synthetic biology and RNA analysis. | Booth Exhibiting at Booth 922, MR15 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 10:00am–10:50am One Sample, Many Insights: Multiomic Profiling in cfDNA and cfRNA Samples Running cfDNA and cfRNA analysis from one liquid biopsy sample, with NEB extraction and NGS library preparation workflows. |
Cellecta Mountain View, CA | |
Genomic products and services for drug target and biomarker discovery: viral vector production, functional screening, cell engineering and multiplex qRT-PCR. | Booth Exhibiting at Booth 2205 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm From Repertoire to Response: A Workflow for Mapping Antigen-Specific T- and B-Cell Clonotypes for Receptor-Based Target Discovery Pairing immune receptor sequencing with antigen screening to rank tumour-specific T- and B-cell clonotypes, including from plasma. Workshop Sat, Nov 14 9:30am–10:00am Discovery and Validation of T- and B-Cell Clonotypes to Drive Next-Level Drug and Biomarker Discovery An end-to-end route from bulk and single-cell receptor sequencing to screening that surfaces drug and biomarker candidates. |
Countable Labs Palo Alto, CA | |
Countable PCR uses single-molecule isolation for fusion and rare variant detection, minimal residual disease monitoring and absolute ctDNA quantification. | Booth Exhibiting at Booth 943 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly. |
Covaris Woburn, MA | |
Sample preparation for multiomics research and clinical labs, using focused-acoustics instruments, consumables, reagents and kits. A PerkinElmer company. | Booth Exhibiting at Booth 2409 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 3:00pm–3:50pm Optimizing FFPE tissue stewardship: Covaris truXTRAC® automated workflow delivers excellent performance for tumor-informed Haystack MRD® assay Getting more DNA and RNA from each FFPE slide so scarce tumour tissue stretches across several sequencing assays. Workshop Thu, Nov 12 3:45pm–4:15pm Optimized Automated Extraction for FFPE Tissue Cores Automated simultaneous DNA and RNA extraction from FFPE cores and sections, validated for sequencing-grade yield. |
Guardant Health Palo Alto, CA | |
Precision oncology company offering blood and tissue tests, real-world data and AI analytics for cancer care. | Booth Exhibiting at Booth 1043 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm Building Scalable Clinical Genomics Workflows: Practical Lessons from Leading Laboratories Scaling sequencing operations in molecular labs, plus how to keep trust in AI-assisted variant interpretation. |
PacBio Menlo Park, CA | |
Sequencing technologies combining long reads with high accuracy for genomes, transcriptomes and epigenomes. | Booth Exhibiting at Booth 1018 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 9:00am–9:50am Full Stack Somatic: Connecting Long-Read HiFi WGS to Clinical Genomic Reporting A containerized somatic long-read whole-genome pipeline running from raw data through variant interpretation to a clinical report. Workshop Fri, Nov 13 12:00pm–12:30pm Accelerating Clinical Genomics with HiFi Sequencing: Targeted and Rapid Whole-Genome Workflows Long-read workflows for repeat expansion disorders and other hard genomic regions, plus a faster whole-genome protocol. |
Vazyme Nanjing, China | |
Designs and manufactures bioactive proteins and recombinant enzymes plus high-performance materials for life science research and in vitro diagnostics. | Booth Exhibiting at Booth 1803 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 1:00pm–1:50pm Intelligent Labs Era: Full Premix Technology Paves the Way for High-Efficiency qPCR A single-tube premixed qPCR formulation aimed at fewer pipetting steps and steadier amplification results. |
Thermo Fisher Scientific Waltham, MA | |
Research and diagnostic solutions for molecular laboratories: next-generation sequencing, real-time PCR, Sanger sequencing and bioinformatics across oncology, pharmacogenomics and infectious disease. | Booth Exhibiting at Booth 709, MR10, MR4 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Silver Partner Workshop Wed, Nov 11 10:00am–10:50am Beyond Tissue: Implementing Alternative Analytes for Molecular Diagnostics in Clinical Practice Using cerebrospinal fluid and fine needle aspirate supernatant for sequencing when tumour tissue is scarce or unavailable. Workshop Wed, Nov 11 11:00am–11:50am Novel NGS Applications in Oncology Research: TCR Sequencing and Methylation-Based ctDNA Analysis T-cell receptor sequencing and methylation-based circulating tumor DNA analysis open new angles on immune response and tumor signals. Workshop Wed, Nov 11 12:00pm–12:50pm Workshop Wed, Nov 11 1:00pm–1:50pm Implementing Clinical Pharmacogenomics: Practical Lessons from Assay to Actionable Care Getting pharmacogenomic testing into routine care: test selection, lab workflow, reporting, reimbursement and health record integration. Workshop Wed, Nov 11 2:00pm–2:50pm Advancing Precision Oncology Research: Integrating Pharmacogenomics and Genomic Profiling Using a Single, Rapid NGS Workflow on the Genexus System Folding DPYD pharmacogenomic content into tumour sequencing so one run covers both drug-response and tumour profiling. Workshop Wed, Nov 11 3:00pm–3:50pm Bridging the Clinical Gap: Retrospective Microsatellite Instability Testing to Inform Complex Biospecimen Cohort Generation Microsatellite instability testing across hundreds of banked tumor specimens builds characterized cohorts for immunotherapy research. Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. Workshop Wed, Nov 11 9:00am–9:50am From Assay to Answer: Genomic Technologies and Multiplex Workflow Solutions for Infectious Disease Research Pathogen detection by qPCR and digital PCR, with assay design and multiplexing choices for adding targets within one reaction. Workshop Thu, Nov 12 4:25pm–4:55pm It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification. Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking New Possibilities in Myeloid Malignancies MRD Assessment with NGS An NGS assay for measurable residual disease in myeloid cancers, covering its gene content, workflow and reported performance. |
GenomOncology Cleveland, OH | |
Clinical decision support for molecular pathology and oncology: sequencer integration, variant annotation, clinical trial matching and customizable reporting. | Booth Exhibiting at Booth 2204, MR11 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Built for the Lab You Actually Run: A Deep Dive Into Configurable Tertiary Analysis Configurable variant interpretation software judged against real lab deployments, from curation and liquid biopsy to structured reporting. Workshop Wed, Nov 11 9:00am–9:50am Full Stack Somatic: Connecting Long-Read HiFi WGS to Clinical Genomic Reporting A containerized somatic long-read whole-genome pipeline running from raw data through variant interpretation to a clinical report. Workshop Thu, Nov 12 6:15pm–6:45pm One Platform, Every Lab: Comprehensive Tertiary Analysis that Adapts to How You Test A single platform handles somatic and germline panels together, adapting to each lab's classification rules and reporting standards. |
LGC Teddington, UK | |
Quality controls, reference materials, diagnostic panels, NGS controls and proficiency testing for clinical laboratories, through its SeraCare clinical diagnostics business. | Booth Exhibiting at Booth 1804, MR13 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm You’re So Naïve: Best Practices and Gold-Standard Reference Material for Tumor-Agnostic MRD Testing Tumor-agnostic residual disease assays face validation hurdles, weighed against tumor-informed testing alongside reference materials. |
QIAGEN Venlo, Netherlands | |
Sample preparation kits, assay technologies and bioinformatics for extracting DNA and RNA insights in research, clinical and applied testing laboratories. | Booth Exhibiting at Booth 529, MR18 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 1:00pm–1:50pm Advancing Cell-Free Nucleic Acid Testing: Integrated Workflows for Prenatal and Oncology Applications Cell-free DNA and RNA workflows for prenatal screening and oncology, including why DNA-only sequencing misses actionable fusions. Workshop Wed, Nov 11 2:00pm–2:50pm Building Scalable Clinical Genomics Workflows: Practical Lessons from Leading Laboratories Scaling sequencing operations in molecular labs, plus how to keep trust in AI-assisted variant interpretation. |
Arima Genomics Carlsbad, CA | |
Cancer diagnostics from whole-genome sequence and structure; runs the CLIA-certified Aventa clinical lab and supplies research kits and informatics. | Booth Exhibiting at Booth 536 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm Aventa Clinical Testing Powered by Arima Hi-C: Revealing Actionable Genomic Structure Across Lymphoma, Lung Cancer, and Sarcoma Hi-C sequencing of FFPE tissue to map fusions and rearrangements in lymphoma, lung cancer and sarcoma cases. |
AstraZeneca Cambridge, UK | |
Biopharmaceutical company developing prescription medicines in oncology; cardiovascular, renal and metabolism; and respiratory disease. | Booth Exhibiting at Booth 820 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Diamond Partner Workshop Wed, Nov 11 4:00pm–4:50pm From Manual to Automated Tissue Dissection: Real-World Experiences with the Tissector TT™ Laboratories describe swapping manual tissue dissection for an automated instrument, and what implementation took. |
Biocartis Mechelen, Belgium | |
Idylla platform delivering in-house molecular biomarker results in about three hours, with diagnostic tests and research assays across several cancers. | Booth Exhibiting at Booth 623 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Decentralized Precision Testing: AI, Gene Signatures, and Rapid Biomarker Testing in Real-World Settings Rapid biomarker testing and AI tools deployed in community health systems alongside academic cancer centres. |
biomodal Saffron Walden, UK | |
Multiomic sequencing chemistry resolving genetic variants and DNA methylation, including 5mC and 5hmC, from a single low-input DNA, cfDNA or FFPE sample. | Booth Exhibiting at Booth 2116 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Thu, Nov 12 4:25pm–4:55pm Integrated genetic, epigenetic and fragmentomic profiling with duet supports ctDNA detection and liquid biopsy biomarker discovery One workflow reads sequence variants, methylation and fragment patterns from the same cell-free DNA, lowering the detection limit for ctDNA. |
Bionano Genomics San Diego, CA | |
Optical genome mapping systems, genome analysis software and nucleic acid extraction products for research and clinical genomics. | Booth Exhibiting at Booth 825 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Silver Partner Workshop Wed, Nov 11 10:00am–10:50am Optical Genome Mapping in Hematologic Malignancies: Optimized Workflows to Uniquely Detect Cytogenomic Variants in Hematologic Malignancies Optical genome mapping workflows for leukemia, and evidence it finds significant structural variants that standard cytogenetics can miss. |
Broad Clinical Labs Burlington, MA | |
CLIA-certified, CAP-accredited subsidiary of the Broad Institute offering multi-omic data generation and analysis for research, translational and clinical use. | Booth Exhibiting at Booth 2304 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Talk Sat, Nov 14 3:30pm–4:00pm Base-Resolution Multiomic Profiling for Rare Cancers and Beyond Machine learning on multiomic cell-free DNA classifies pediatric solid tumors such as Wilms tumor and sarcoma from limited samples. |
Bruker Molecular Diagnostics Bothell, WA | |
Molecular infection diagnostics on the BeGenius platform, plus sepsis workflow, microbial identification, strain typing and infection-control tools. | Booth Exhibiting at Booth 2401 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 11:00am–11:50am Analytical Evaluation of the ELITe® DSQ Alert® Measles Real-Time PCR Assay on the ELITe BeGenius® and InGenius® Sample-To-Result Automated Systems Measles RT-PCR on automated sample-to-result systems, validated to tell wild-type virus from vaccine strain by melt curve. Workshop Fri, Nov 13 9:30am–10:00am Closing the Bloodstream Infection Diagnostic Gap: Rapid Identification and Phenotypic MIC Determination from Positive Blood Cultures Faster species identification and phenotypic susceptibility results straight from positive blood cultures in suspected sepsis. |
Clear Labs San Carlos, CA | |
Automated next-generation sequencing platform combining DNA sequencing, robotics and cloud bioinformatics for clinical and public health genomics. | Booth Exhibiting at Booth 743 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am From Hands-On to Hands-Off: Automating FFPE, Blood, and Bone Marrow Extraction on the Clear Dx System Automated nucleic acid extraction from FFPE, blood and bone marrow, with yield reproducibility, contamination checks and time saved. Workshop Wed, Nov 11 9:00am–9:50am Streamlined Comprehensive Genomic Profiling on Clear Dx: Automated Extraction and Library Prep on One Platform Automating extraction and library prep for a tumor profiling panel, compared with the manual workflow on clinical FFPE specimens. |
Element Biosciences San Diego, CA | |
AVITI24 sequencing platform integrating transcriptomic, proteomic and morphologic data at single-cell resolution, using proprietary Avidite chemistry. | Booth Exhibiting at Booth 505 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am VITARI High-Throughput Sequencing: Platform Performance, Third-Party Benchmarking, and Early Independent Comparison with Existing Platforms Specs, third-party benchmarks and an outside lab's early comparison of the VITARI high-throughput sequencer with established platforms. Workshop Wed, Nov 11 9:00am–9:50am Analytical Performance of SOPHiA GENETICS MSK-IMPACT Flex on AVITI24 and Initial Compatibility of Trinity On-Flow Cell Hybrid Capture Verification data for a SOPHiA comprehensive genomic profiling panel on AVITI24, plus early results from Trinity on-flow-cell hybrid capture. |
Fapon Biotech Dongguan, China | |
In vitro diagnostics supplier of reagent raw materials, reagent services and open instrument platforms for partners worldwide. | Booth Exhibiting at Booth 1905 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 10:00am–10:50am Unlocking the Full Potential of Enzymes in Molecular Diagnostics Engineered enzymes for PCR, isothermal amplification and sequencing prep, including a reverse transcriptase tuned for long-read libraries. |
Find buyers from AMP 2026 exhibitors
Tell us what you sell and we’ll find the people at these exhibitors most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse AMP 2026 by
Organization type
Program track
Exhibit hall
- Exhibitors 183
Everyone
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction